Lipid‐based nanoparticles for contrast‐enhanced MRI and molecular imaging

In the field of MR imaging and especially in the emerging field of cellular and molecular MR imaging, flexible strategies to synthesize contrast agents that can be manipulated in terms of size and composition and that can be easily conjugated with targeting ligands are required. Furthermore, the relaxivity of the contrast agents, especially for molecular imaging applications, should be very high to deal with the low sensitivity of MRI. Lipid‐based nanoparticles, such as liposomes or micelles, have been used extensively in recent decades as drug carrier vehicles. A relatively new and promising application of lipidic nanoparticles is their use as multimodal MR contrast agents. Lipids are amphiphilic molecules with both a hydrophobic and a hydrophilic part, which spontaneously assemble into aggregates in an aqueous environment. In these aggregates, the amphiphiles are arranged such that the hydrophobic parts cluster together and the hydrophilic parts face the water. In the low concentration regime, a wide variety of structures can be formed, ranging from spherical micelles to disks or liposomes. Furthermore, a monolayer of lipids can serve as a shell to enclose a hydrophobic core. Hydrophobic iron oxide particles, quantum dots or perfluorocarbon emulsions can be solubilized using this approach. MR‐detectable and fluorescent amphiphilic molecules can easily be incorporated in lipidic nanoparticles. Furthermore, targeting ligands can be conjugated to lipidic particles by incorporating lipids with a functional moiety to allow a specific interaction with molecular markers and to achieve accumulation of the particles at disease sites. In this review, an overview of different lipidic nanoparticles for use in MRI is given, with the main emphasis on Gd–based contrast agents. The mechanisms of particle formation, conjugation strategies and applications in the field of contrast‐enhanced, cellular and molecular MRI are discussed. Copyright © 2006 John Wiley & Sons, Ltd.

[1]  Rika Takikawa,et al.  [In-vivo visualization of gene expression using magnetic resonance imaging]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[2]  H. Weinmann,et al.  Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography , 1999, Magnetic Resonance Materials in Physics, Biology and Medicine.

[3]  Klaas Nicolay,et al.  Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. , 2006, Nano letters.

[4]  Klaas Nicolay,et al.  MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  K. Nicolay,et al.  Relaxivity of liposomal paramagnetic MRI contrast agents , 2005, Magnetic Resonance Materials in Physics, Biology and Medicine.

[6]  Enzo Terreno,et al.  Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. , 2005, Angewandte Chemie.

[7]  Eric T Ahrens,et al.  In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.

[8]  Valérie Cabuil,et al.  Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. , 2005, Journal of the American Chemical Society.

[9]  Marcelino Bernardo,et al.  Gadolinium-rhodamine nanoparticles for cell labeling and tracking via magnetic resonance and optical imaging. , 2005, Bioconjugate chemistry.

[10]  J. Baselga,et al.  Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Walter H Backes,et al.  Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice. , 2005, Radiology.

[12]  C. Wessig,et al.  Assessment of nerve degeneration by gadofluorine M–enhanced magnetic resonance imaging , 2005, Annals of neurology.

[13]  M. Ferrari Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[14]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Ralph Weissleder,et al.  Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.

[16]  V. Torchilin Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[17]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[18]  V. Torchilin Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate. , 2005, Advanced drug delivery reviews.

[19]  Shelton D Caruthers,et al.  Molecular imaging of human thrombus with computed tomography. , 2005, Academic radiology.

[20]  V. Pierre,et al.  Next generation, high relaxivity gadolinium MRI agents. , 2005, Bioconjugate chemistry.

[21]  Daowen Wang,et al.  [Correlation of thrombospondin-1 G1678A polymorphism to stroke: a study in Chinese population]. , 2004, Zhonghua yi xue za zhi.

[22]  Patrick J. Gaffney,et al.  Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticles , 2004 .

[23]  C. Benz,et al.  Future directions of liposome- and immunoliposome-based cancer therapeutics. , 2004, Seminars in oncology.

[24]  Atle Bjørnerud,et al.  Experimental application of thermosensitive paramagnetic liposomes for monitoring magnetic resonance imaging guided thermal ablation , 2004, Magnetic resonance in medicine.

[25]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[26]  Zahi A Fayad,et al.  Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. , 2004, Journal of the American Chemical Society.

[27]  R. Zhou,et al.  MR and fluorescent imaging of low-density lipoprotein receptors. , 2004, Academic radiology.

[28]  Jeff W M Bulte,et al.  Iron oxide MR contrast agents for molecular and cellular imaging , 2004, NMR in biomedicine.

[29]  Shelton D Caruthers,et al.  Magnetic resonance molecular imaging with nanoparticles , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[30]  Zahi A. Fayad,et al.  Molecular, cellular and functional imaging of atherothrombosis , 2004, Nature Reviews Drug Discovery.

[31]  B. Marincek,et al.  Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging. , 2004, Radiology.

[32]  V. Torchilin,et al.  Targeted polymeric micelles for delivery of poorly soluble drugs , 2004, Cellular and Molecular Life Sciences CMLS.

[33]  Stefano Colagrande,et al.  Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma , 2004, Magnetic resonance in medicine.

[34]  Ralph Weissleder,et al.  Magneto/optical annexin V, a multimodal protein. , 2004, Bioconjugate chemistry.

[35]  Kevin M Brindle,et al.  Detection of apoptosis using the C2A domain of synaptotagmin I. , 2004, Bioconjugate chemistry.

[36]  Xiaoping P. Hu,et al.  Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent , 2004, JBIC Journal of Biological Inorganic Chemistry.

[37]  K. Nicolay,et al.  A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. , 2004, Bioconjugate chemistry.

[38]  V. Fuster,et al.  Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging , 2004, Circulation.

[39]  H. Weinmann,et al.  Early MR lymphography with gadofluorine M in rabbits. , 2004, Radiology.

[40]  M. Dewhirst,et al.  In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery , 2004, Magnetic resonance in medicine.

[41]  Vladimir P Torchilin,et al.  Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. , 2004, Advanced drug delivery reviews.

[42]  J. Heverhagen,et al.  Encapsulation of gadobutrol in AVE-based liposomal carriers for MR detectability. , 2004, Magnetic resonance imaging.

[43]  M. Berger,et al.  Extensive Distribution of Liposomes in Rodent Brains and Brain Tumors Following Convection-Enhanced Delivery , 2004, Journal of Neuro-Oncology.

[44]  Luigi Biancone,et al.  Improved route for the visualization of stem cells labeled with a Gd‐/Eu‐Chelate as dual (MRI and fluorescence) agent , 2004, Magnetic resonance in medicine.

[45]  R. Kontermann,et al.  Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells. , 2004, Protein engineering, design & selection : PEDS.

[46]  A. Bjørnerud,et al.  Novel pH‐sensitive paramagnetic liposomes with improved MR properties , 2004, Magnetic resonance in medicine.

[47]  M. Berger,et al.  Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging , 2004, Cancer Research.

[48]  S. Caruthers,et al.  1054-155 Antiangiogenic therapy of early atherosclerosis with paramagnetic ανβ3-integrin-targeted fumagillin nanoparticles , 2004 .

[49]  D Leszczynska,et al.  Principles of magnetodynamic chemotherapy. , 2004, Medical hypotheses.

[50]  Shelton D Caruthers,et al.  Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI , 2004, Magnetic resonance in medicine.

[51]  G. D’Errico,et al.  Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI. , 2004, Journal of the American Chemical Society.

[52]  Ralph Weissleder,et al.  Peroxidase Substrate Nanosensors for MR Imaging , 2004 .

[53]  A. Griffioen,et al.  MR imaging of avb3-expression in tumor bearing mice using RGD-conjugated paramagnetic and fluorescent liposomes , 2004 .

[54]  R. Rein,et al.  Conformational requirements of suramin to target angiogenic growth factors , 2004, Angiogenesis.

[55]  M. Ferrari,et al.  Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group. , 2003, Circulation.

[56]  J. O’Shaughnessy Pegylated liposomal doxorubicin in the treatment of breast cancer. , 2003, Clinical breast cancer.

[57]  K. Edwards,et al.  Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids. , 2003, Biophysical journal.

[58]  Samuel A. Wickline,et al.  Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .

[59]  M. Neeman,et al.  Modulation of the pharmacokinetics of macromolecular contrast material by avidin chase: MRI, optical, and inductively coupled plasma mass spectrometry tracking of triply labeled albumin , 2003, Magnetic resonance in medicine.

[60]  R. Weissleder,et al.  In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. , 2003, Cancer research.

[61]  L. Helm,et al.  8S paramagnetic centres in molecular assemblies: possible effect of their proximity on the water proton relaxivity , 2003 .

[62]  Doris A Taylor,et al.  Improved Efficacy of Stem Cell Labeling for Magnetic Resonance Imaging Studies by the Use of Cationic Liposomes , 2003, Cell transplantation.

[63]  A. Kassner,et al.  Molecular Imaging of Angiogenesis in Nascent Vx-2 Rabbit Tumors Using a Novel ανβ3-targeted Nanoparticle and 1.5 Tesla Magnetic Resonance Imaging , 2003 .

[64]  K. Nicolay,et al.  Interferon-Beta Prevents Cytokine-Induced Neutrophil Infiltration and Attenuates Blood–Brain Barrier Disruption , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[65]  T. Allen,et al.  Ligand-targeted liposomal anticancer drugs. , 2003, Progress in lipid research.

[66]  J. Debatin,et al.  Detection of Atherosclerotic Plaque With Gadofluorine-Enhanced Magnetic Resonance Imaging , 2003, Circulation.

[67]  S. Aime,et al.  Novel radical‐responsive MRI contrast agent based on paramagnetic liposomes , 2003 .

[68]  Sheng-Kwei Song,et al.  Improved molecular imaging contrast agent for detection of human thrombus , 2003, Magnetic resonance in medicine.

[69]  A. Senoo,et al.  Interstitial Magnetic Resonance Lymphography: Comparative Animal Study of Gadofluorine 8 and Gadolinium Diethylenetriamine-Pentaacetic Acid , 2003, Journal of computer assisted tomography.

[70]  J. Klaveness,et al.  pH-sensitive paramagnetic liposomes for MRI: assessment of stability in blood. , 2003, Magnetic resonance imaging.

[71]  Dmitri Artemov,et al.  Magnetic resonance molecular imaging of the HER-2/neu receptor. , 2003, Cancer research.

[72]  M. E. Kooi,et al.  Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.

[73]  Ergin Atalar,et al.  In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.

[74]  Vladimir P. Torchilin,et al.  Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[75]  R. Weissleder,et al.  Near-infrared fluorescent imaging of tumor apoptosis. , 2003, Cancer research.

[76]  J. Klaveness,et al.  Preparation and in vitro evaluation of a novel amphiphilic GdPCTA-[12] derivative; a micellar MRI contrast agent. , 2003, Organic & biomolecular chemistry.

[77]  I. Rubinstein,et al.  Liposomes in ultrasound and gamma scintigraphic imaging. , 2003, Methods in enzymology.

[78]  Shelton D Caruthers,et al.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. , 2003, Circulation.

[79]  J. Bulte,et al.  Magnetoliposomes as contrast agents. , 2003, Methods in enzymology.

[80]  Shelton D Caruthers,et al.  Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. , 2003, Cancer research.

[81]  D. Scherman,et al.  Design, synthesis, and evaluation of gadolinium cationic lipids as tools for biodistribution studies of gene delivery complexes. , 2003, Bioconjugate chemistry.

[82]  P. Libby Inflammation in atherosclerosis , 2002, Nature.

[83]  Carl Nathan,et al.  Points of control in inflammation , 2002, Nature.

[84]  Vincent Noireaux,et al.  In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.

[85]  Kerry K. Karukstis,et al.  Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis , 2002, Circulation.

[86]  Mathias Hoehn,et al.  Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[87]  T. Allen Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.

[88]  A. Padhani Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions , 2002, Journal of magnetic resonance imaging : JMRI.

[89]  M. Bednarski,et al.  Tumor Regression by Targeted Gene Delivery to the Neovasculature , 2002, Science.

[90]  John W. Park Liposome-based drug delivery in breast cancer treatment , 2002, Breast Cancer Research.

[91]  Ulrik B Nielsen,et al.  Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[92]  Jo Klaveness,et al.  Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity. , 2002, International journal of pharmaceutics.

[93]  Vladimir P Torchilin,et al.  PEG-based micelles as carriers of contrast agents for different imaging modalities. , 2002, Advanced drug delivery reviews.

[94]  R. Schiffelers,et al.  Endothelial cells at inflammatory sites as target for therapeutic intervention. , 2002, Endothelium : journal of endothelial cell research.

[95]  Kathy Wilkinson,et al.  Liposomal doxorubicin. , 2002, Clinical journal of oncology nursing.

[96]  Koert N. J. Burger,et al.  Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity , 2002, Nature Medicine.

[97]  F. Khuri,et al.  A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer. , 2001, Lung cancer.

[98]  P. Doevendans,et al.  Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart , 2001, Nature Medicine.

[99]  Ming Zhao,et al.  Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent , 2001, Nature Medicine.

[100]  S A Wickline,et al.  Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.

[101]  A. Bjørnerud,et al.  pH-sensitive paramagnetic liposomes as MRI contrast agents: in vitro feasibility studies. , 2001, Magnetic resonance imaging.

[102]  A. Bjørnerud,et al.  A targeted contrast agent for magnetic resonance imaging of thrombus: Implications of spatial resolution , 2001, Journal of magnetic resonance imaging : JMRI.

[103]  Sibylle Ziegler,et al.  Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography , 2001 .

[104]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[105]  R. Vile,et al.  Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[106]  J. Debatin,et al.  Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.

[107]  D. Shah,et al.  Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. , 2001, Critical reviews in therapeutic drug carrier systems.

[108]  M. Schwaiger,et al.  Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. , 2001, Cancer research.

[109]  A. Bjørnerud,et al.  Thermosensitive paramagnetic liposomes for temperature control during MR imaging-guided hyperthermia: in vitro feasibility studies. , 2000, Academic radiology.

[110]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[111]  W. Oyen,et al.  Radiolabeled liposomes for scintigraphic imaging. , 2000, Progress in lipid research.

[112]  P. Doevendans,et al.  Visualisation of cell death in vivo in patients with acute myocardial infarction , 2000, The Lancet.

[113]  A. Griffioen,et al.  Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. , 2000, Pharmacological reviews.

[114]  L. Steinman,et al.  ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging , 2000, Journal of Neuroimmunology.

[115]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[116]  Peter Babinec,et al.  Site-Specific in vivo Targeting of Magnetoliposomes Using Externally Applied Magnetic Field , 2000, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[117]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[118]  M. Lawrence,et al.  Microemulsion-based media as novel drug delivery systems. , 2000, Advanced drug delivery reviews.

[119]  G.,et al.  Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .

[120]  D. Papahadjopoulos,et al.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.

[121]  Koning,et al.  Immunoliposomes for the targeted delivery of antitumor drugs. , 1999, Advanced drug delivery reviews.

[122]  C H Lorenz,et al.  Contrast‐enhanced coronary MRA , 1999, Journal of magnetic resonance imaging : JMRI.

[123]  A de Roos,et al.  Blood pool contrast agents for cardiovascular MR imaging , 1999, Journal of magnetic resonance imaging : JMRI.

[124]  M. Jones,et al.  Polymeric micelles - a new generation of colloidal drug carriers. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[125]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[126]  Yu-Chung N. Cheng,et al.  Magnetic Resonance Imaging: Physical Principles and Sequence Design , 1999 .

[127]  Oku,et al.  Delivery of contrast agents for positron emission tomography imaging by liposomes. , 1999, Advanced drug delivery reviews.

[128]  J. Bulte,et al.  Short‐ vs. long‐circulating magnetoliposomes as bone marrow‐seeking MR contrast agents , 1999, Journal of magnetic resonance imaging : JMRI.

[129]  R. Muller,et al.  Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity. , 1999, Magnetic resonance imaging.

[130]  R. Davis,et al.  In vivo detection and imaging of phosphatidylserine expression during programmed cell death. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[131]  Enzo Terreno,et al.  Lanthanide(III) chelates for NMR biomedical applications , 1998 .

[132]  M. Bednarski,et al.  Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. , 1998, Nature medicine.

[133]  R. Schiffelers,et al.  Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents. , 1997, Molecular pharmacology.

[134]  G. Groenewegen,et al.  CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. , 1997, Blood.

[135]  W. Chu,et al.  In vivo Characterization of Gd(BME‐DTTA), a myocardial MRI contrast agent: tissue distribution of its MRI intensity enhancement, and its effect on heart function , 1997, NMR in biomedicine.

[136]  D. Crommelin,et al.  Colloidal systems for tumor targeting. , 1997, Hybridoma.

[137]  T. Allen,et al.  Liposomes , 2012, Drugs.

[138]  J. G. Miller,et al.  A novel site-targeted ultrasonic contrast agent with broad biomedical application. , 1996, Circulation.

[139]  King Li,et al.  Paramagnetic polymerized liposomes as new recirculating MR contrast agents , 1995, Journal of magnetic resonance imaging : JMRI.

[140]  King C.P. Li,et al.  Paramagnetic Polymerized Liposomes: Synthesis, Characterization, and Applications for Magnetic Resonance Imaging , 1995 .

[141]  V. Torchilin,et al.  Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties. , 1995, Magnetic resonance imaging.

[142]  T. Allen Long-circulating (sterically stabilized) liposomes for targeted drug delivery. , 1994, Trends in pharmacological sciences.

[143]  N. Phillips,et al.  Immunoliposome targeting to murine CD4+ leucocytes is dependent on immune status. , 1994, Journal of immunology.

[144]  E. Unger,et al.  Manganese-Based Liposomes Comparative Approaches , 1993, Investigative radiology.

[145]  T. Singleton,et al.  Stability of HER-2/neu expression over time and at multiple metastatic sites. , 1993, Journal of the National Cancer Institute.

[146]  J. Bulte,et al.  Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran‐magnetite particles , 1993, Magnetic resonance in medicine.

[147]  Physics of Amphiphiles : Micelles , Vesicles and Microemulsion , 1993 .

[148]  S. H. Koenig,et al.  The design of liposomal paramagnetic mr agents: effect of vesicle size upon the relaxivity of surface‐incorporated lipophilic chelates , 1992, Magnetic resonance in medicine.

[149]  Stefan Miltenyi,et al.  Specific MR imaging of human lymphocytes by monoclonal antibody‐guided dextran‐magnetite particles , 1992, Magnetic resonance in medicine.

[150]  E. Unger,et al.  Permeability of liposomal membranes to water: Results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions , 1992, Magnetic resonance in medicine.

[151]  E. Unger,et al.  Liposomes as MR contrast agents: Pros and cons , 1991, Magnetic resonance in medicine.

[152]  G. Pohost,et al.  Fatty‐acyl iminopolycarboxylates: Lipophilic bifunctional contrast agents for NMR imaging , 1991, Magnetic resonance in medicine.

[153]  T. Allen,et al.  Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.

[154]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[155]  K. Hubner,et al.  Gadolinium‐labeled liposomes containing various amphiphilic Gd‐DTPA derivatives: Targeted MRI contrast enhancement agents for the liver , 1991, Magnetic resonance in medicine.

[156]  M. Botta,et al.  Trends in NMR studies of paramagnetic Gd(III) complexes as potential contrast agents in MRI , 1991 .

[157]  L. Huang,et al.  Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: targeted MRI contrast enhancement agents for the liver. , 1991, Magnetic resonance imaging.

[158]  M. de Cuyper,et al.  Potentialities of magnetoliposomes in studying symmetric and asymmetric phospholipid transfer processes. , 1990, Biochimica et biophysica acta.

[159]  G. V. von Schulthess,et al.  A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents. , 1990, Investigative radiology.

[160]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[161]  A. Siccardi,et al.  Intraperitoneal radio‐localization of tumors pre‐targeted by biotinylated monoclonal antibodies , 1990, International journal of cancer.

[162]  S M Wright,et al.  Liposome encapsulated MnCl2 as a liver specific contrast agent for magnetic resonance imaging. , 1990, Investigative radiology.

[163]  K. Hubner,et al.  Gd-labeled liposomes containing amphipathic agents for magnetic resonance imaging. , 1990, Investigative radiology.

[164]  R. Gatenby,et al.  Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging. , 1989, Radiology.

[165]  P. Cullis,et al.  Liposomal Gd-DTPA: preparation and characterization of relaxivity. , 1989, Radiology.

[166]  P. Needleman,et al.  Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress. , 1988, Investigative radiology.

[167]  J. Devoisselle,et al.  Entrapment of gadolinium-DTPA in liposomes. Characterization of vesicles by P-31 NMR spectroscopy. , 1988, Investigative radiology.

[168]  K. Hubner,et al.  Gadolinium‐labeled liposomes containing paramagnetic amphipathic agents: Targeted MRI contrast agents for the liver , 1988, Magnetic resonance in medicine.

[169]  S. H. Koenig,et al.  Relaxivity and binding of Mn2+ ions in solutions of phosphatidylserine vesicles , 1988, Magnetic resonance in medicine.

[170]  M. de Cuyper,et al.  Magnetoliposomes , 1988, European Biophysics Journal.

[171]  G. Navon,et al.  Liposomes containing paramagnetic macromolecules as MRI contrast agents , 1986, Magnetic resonance in medicine.

[172]  S M Wright,et al.  Liposome delivery of NMR contrast agents for improved tissue imaging , 1986, Magnetic resonance in medicine.

[173]  J. Gore,et al.  Relaxation enhancement using liposomes carrying paramagnetic species. , 1984, Magnetic resonance imaging.

[174]  V A Namiot,et al.  Magnetoliposomes: another principle of cell sorting. , 1983, Biochimica et biophysica acta.

[175]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[176]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.